These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Activation of the Raf-1/MAP kinase cascade is not sufficient for Ras transformation of RIE-1 epithelial cells. Oldham SM; Clark GJ; Gangarosa LM; Coffey RJ; Der CJ Proc Natl Acad Sci U S A; 1996 Jul; 93(14):6924-8. PubMed ID: 8692920 [TBL] [Abstract][Full Text] [Related]
8. Oncogenic Ras and transforming growth factor-beta synergistically regulate AU-rich element-containing mRNAs during epithelial to mesenchymal transition. Kanies CL; Smith JJ; Kis C; Schmidt C; Levy S; Khabar KS; Morrow J; Deane N; Dixon DA; Beauchamp RD Mol Cancer Res; 2008 Jul; 6(7):1124-36. PubMed ID: 18644977 [TBL] [Abstract][Full Text] [Related]
9. Ras inactivation of the retinoblastoma pathway by distinct mechanisms in NIH 3T3 fibroblast and RIE-1 epithelial cells. Pruitt K; Pestell RG; Der CJ J Biol Chem; 2000 Dec; 275(52):40916-24. PubMed ID: 11007784 [TBL] [Abstract][Full Text] [Related]
11. Ras and TGF[beta] cooperatively regulate epithelial cell plasticity and metastasis: dissection of Ras signaling pathways. Janda E; Lehmann K; Killisch I; Jechlinger M; Herzig M; Downward J; Beug H; Grünert S J Cell Biol; 2002 Jan; 156(2):299-313. PubMed ID: 11790801 [TBL] [Abstract][Full Text] [Related]
12. Synergistic effect between EGF and TGF-beta1 in inducing oncogenic properties of intestinal epithelial cells. Uttamsingh S; Bao X; Nguyen KT; Bhanot M; Gong J; Chan JL; Liu F; Chu TT; Wang LH Oncogene; 2008 Apr; 27(18):2626-34. PubMed ID: 17982486 [TBL] [Abstract][Full Text] [Related]
13. Oncogenic Ras blocks anoikis by activation of a novel effector pathway independent of phosphatidylinositol 3-kinase. McFall A; Ulkü A; Lambert QT; Kusa A; Rogers-Graham K; Der CJ Mol Cell Biol; 2001 Aug; 21(16):5488-99. PubMed ID: 11463831 [TBL] [Abstract][Full Text] [Related]
14. A raf-independent epidermal growth factor receptor autocrine loop is necessary for Ras transformation of rat intestinal epithelial cells. Gangarosa LM; Sizemore N; Graves-Deal R; Oldham SM; Der CJ; Coffey RJ J Biol Chem; 1997 Jul; 272(30):18926-31. PubMed ID: 9228072 [TBL] [Abstract][Full Text] [Related]
15. Ras-mediated loss of the pro-apoptotic response protein Par-4 is mediated by DNA hypermethylation through Raf-independent and Raf-dependent signaling cascades in epithelial cells. Pruitt K; Ulkü AS; Frantz K; Rojas RJ; Muniz-Medina VM; Rangnekar VM; Der CJ; Shields JM J Biol Chem; 2005 Jun; 280(24):23363-70. PubMed ID: 15831492 [TBL] [Abstract][Full Text] [Related]
16. Type II TGF(beta) receptor expression in intestinal cell lines and in the intestinal tract. Winesett MP; Ramsey GW; Barnard JA Carcinogenesis; 1996 May; 17(5):989-95. PubMed ID: 8640948 [TBL] [Abstract][Full Text] [Related]
17. Ras, but not Src, transformation of RIE-1 epithelial cells is dependent on activation of the mitogen-activated protein kinase cascade. Oldham SM; Cox AD; Reynolds ER; Sizemore NS; Coffey RJ; Der CJ Oncogene; 1998 May; 16(20):2565-73. PubMed ID: 9632133 [TBL] [Abstract][Full Text] [Related]
18. Oncogenes and tumor angiogenesis: differential modes of vascular endothelial growth factor up-regulation in ras-transformed epithelial cells and fibroblasts. Rak J; Mitsuhashi Y; Sheehan C; Tamir A; Viloria-Petit A; Filmus J; Mansour SJ; Ahn NG; Kerbel RS Cancer Res; 2000 Jan; 60(2):490-8. PubMed ID: 10667605 [TBL] [Abstract][Full Text] [Related]
19. Ras mediates radioresistance through both phosphatidylinositol 3-kinase-dependent and Raf-dependent but mitogen-activated protein kinase/extracellular signal-regulated kinase kinase-independent signaling pathways. Grana TM; Rusyn EV; Zhou H; Sartor CI; Cox AD Cancer Res; 2002 Jul; 62(14):4142-50. PubMed ID: 12124353 [TBL] [Abstract][Full Text] [Related]
20. Transformation of intestinal epithelial cells by chronic TGF-beta1 treatment results in downregulation of the type II TGF-beta receptor and induction of cyclooxygenase-2. Sheng H; Shao J; O'Mahony CA; Lamps L; Albo D; Isakson PC; Berger DH; DuBois RN; Beauchamp RD Oncogene; 1999 Jan; 18(4):855-67. PubMed ID: 10023661 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]